Cryosite Ltd
ASX:CTE
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
Cryosite Ltd
Total Current Assets
Cryosite Ltd
Total Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Cryosite Ltd
ASX:CTE
|
Total Current Assets
AU$6.5m
|
CAGR 3-Years
-8%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
0%
|
|
|
Genetic Technologies Ltd
ASX:GTG
|
Total Current Assets
AU$1.7m
|
CAGR 3-Years
-53%
|
CAGR 5-Years
-15%
|
CAGR 10-Years
-3%
|
|
|
Anteotech Ltd
ASX:ADO
|
Total Current Assets
AU$1.6m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
-16%
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Total Current Assets
AU$8m
|
CAGR 3-Years
4%
|
CAGR 5-Years
0%
|
CAGR 10-Years
N/A
|
|
|
T
|
Trajan Group Holdings Ltd
ASX:TRJ
|
Total Current Assets
AU$67.6m
|
CAGR 3-Years
1%
|
CAGR 5-Years
18%
|
CAGR 10-Years
N/A
|
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Total Current Assets
AU$33m
|
CAGR 3-Years
33%
|
CAGR 5-Years
40%
|
CAGR 10-Years
N/A
|
|
Cryosite Ltd
Glance View
Cryosite Ltd. engages in the provision of long term storage, supply chain logistics management of pharmaceutical products used in clinical trials and biological materials. The company is headquartered in Sydney, New South Wales. The company went IPO on 2002-05-09. The firm operates through two segments, which include Clinical Trials and Biological Services Logistics, and Cord Blood and Tissue Storage. The Clinical Trials and Biological Services Logistics segment provides specialist temperature-controlled storage, sourcing, labelling, status management, secondary packaging, schedule drug distribution, destruction, returns and biological services to the clinical trial and research industry. The Cord Blood and Tissue Storage segment provides long-term storage for cord blood and tissue samples. The firm engages in clinical trial supply chain from importation, receipt, specialized ambient, cold, frozen, and liquid nitrogen storage for temperature-sensitive products, distribution, and reverse logistics management.
See Also
What is Cryosite Ltd's Total Current Assets?
Total Current Assets
6.5m
AUD
Based on the financial report for Dec 31, 2025, Cryosite Ltd's Total Current Assets amounts to 6.5m AUD.
What is Cryosite Ltd's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
0%
Over the last year, the Total Current Assets growth was -16%. The average annual Total Current Assets growth rates for Cryosite Ltd have been -8% over the past three years , -1% over the past five years .
